Yali Gao
Yinchuan, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Reprogramming tumour-associated macrophages in breast cancer via si-FOXM1-loaded lipid nanoparticles enhances immune checkpoint inhibitor efficacy.
Journal: British journal of pharmacology
Published: March 13, 2025
LncRNA TCL6 regulates miR-876-5p/MYL2 axis to suppress breast cancer progression.
Journal: Translational oncology
Published: April 28, 2024
Exosomes Derived from Tumor Cells Initiate Breast Cancer Cell Metastasis and Chemoresistance through a MALAT1-Dependent Mechanism.
Journal: Journal of oncology
Published: December 10, 2021
HINT3 suppresses AKT/mTOR signaling pathway activity during breast cancer tumorigenesis through PTEN transcriptional activation.
Journal: International journal of molecular medicine
Published: November 12, 2021
DNA methyltransferase 1 inhibits microRNA-497 and elevates GPRC5A expression to promote chemotherapy resistance and metastasis in breast cancer.
Journal: Cancer cell international
Published: July 11, 2021
Expression and promoter methylation status of OPCML and its functions in the inhibition of cell proliferation, migration, and invasion in breast cancer.
Journal: Breast cancer (Tokyo, Japan)
Published: July 16, 2020
Elevating microRNA-1-3p shuttled by cancer-associated fibroblasts-derived extracellular vesicles suppresses breast cancer progression and metastasis by inhibiting GLIS1.
Journal: Cancer gene therapy
Published: April 05, 2020
Showing 1-8 of 8
Last Updated: 09/26/2026